.Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J04A_DrugsForTreatmentOfTuberculosis.J04AA01_D_4AminosalicylicAcid.D_4AminosalicylicAcid .Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J04A_DrugsForTreatmentOfTuberculosis.J04AA01_D_4AminosalicylicAcid.D_4AminosalicylicAcid| name: | D_4AminosalicylicAcid | |
| ATC code: | J04AA01 | |
| route: | oral | |
| compartments: | 1 | |
| dosage: | 4000 | mg |
| volume of distribution: | 10 | L |
| clearance: | 7 | L/h |
| other parameters in model implementation | ||
4-aminosalicylic acid (PAS) is an antimycobacterial agent used primarily in the treatment of tuberculosis, especially multidrug-resistant strains. It is typically utilized in combination regimens. While it was a mainstay prior to the advent of more effective drugs, PAS is currently approved and reserved mainly for drug-resistant cases.
Pharmacokinetic parameters in healthy adult subjects after oral administration.